What Happened?
San Diego, CA-based Ligand Promoted Octavio Espinoza as Chief Financial Officer
Date of management change: November 01, 2022
San Diego, CA-based Ligand Promoted Octavio Espinoza as Chief Financial Officer
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue. Visit our technical products: omniab.com, captisol.com, vernalis.com and ltptechnology.com.
Octavio Espinoza is Chief Financial Officer at Ligand. Previously, Octavio held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Jankowski Ryan, Borton Deborah, Cody Angela, Bernstein Michael, Roy Lindsey, Huff Stephanie, Presley Hannah, Krackeler Tom, Berman Lisa, Foti John, Wallace Tracey
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.